The data for the proliferating cell nuclear antigen (PCNA), TP53 gene-encoded p53 protein (p53), and polycomb inhibitory complex catalytic subunit 2 (EZH2) markers tested in the tumor are presented in Table A4, Table A5 and Table A6 in Appendix A. This evidence concerns the gene PCNA and neoplasm.